financetom
Business
financetom
/
Business
/
CarMax, Inc. (KMX) Shares Fall Again Amid Disclosure of Expected Comparable Store Unit Sales Decline, Class Action Pending -- Hagens Berman
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CarMax, Inc. (KMX) Shares Fall Again Amid Disclosure of Expected Comparable Store Unit Sales Decline, Class Action Pending -- Hagens Berman
Nov 24, 2025 12:39 PM

SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- On November 6, 2025, investors in CarMax ( KMX ), Inc.  saw shares plummet $9.93 (-24%) after the company announced that it fired CEO Bill Nash and issued its new Q3 2026 preliminary outlook on comparable store used unit sales, calling for a decline of 8%-12% from a year ago.

The developments are the latest following CarMax’s dismal Q2 2026 results, which drove the share price down $11.45 (-20%) on September 25, 2025.

National shareholders rights firm Hagens Berman continues to investigate the legal claims alleged in the pending securities class action.

The firm urges investors in CarMax ( KMX ) who suffered significant losses during the Class Period to submit your losses now.

Class Period: June 20, 2025Nov. 5, 2025
Lead Plaintiff Deadline: Jan. 2, 2026
Visit: www.hbsslaw.com/investor-fraud/kmx
Contact the Firm Now:  [email protected]
  844-916-0895

CarMax, Inc. ( KMX ) Securities Class Action Litigation: 

The litigation is focused on the propriety of CarMax’s disclosures about the strength of its business model and growth prospects.

More specifically, on June 20, 2025, CarMax ( KMX ) touted double digit Q1 2026 EPS growth and assured investors that “a fragmented market that positions us to continue to drive sales, gain market share, and deliver year-over-year earnings growth for years to come.”

The complaint alleges that CarMax ( KMX ) misled investors about its prospects, was in no position to assure investors of earnings growth for years to come, and failed to disclose that its Q1 2026 results were positive because of consumers’ pulling forward their car purchases to avoid tariffs.

Investors allegedly began to learn the truth on September 25, 2025. That day, CarMax ( KMX ) reported dismal Q2 2026 financial results. Year-over-year, the company’s net EPS fell a whopping 24%, retail used unit sales fell 5.4%, and comparable store used unit sales fell 6.3%.

In addition, questions arose about the quality of the company’s CarMax Auto Finance (CAF) loan portfolio. The company reported that CAF’s revenue declined 11.02% year-over-year due to a $142 million loan loss provision even though management had previously assured investors that “we feel good about our reserve[.]” This figure represents a sequential increase of nearly 40% and a year-over-year jump of approximately 24%.

Then, on November 6, 2025, CarMax ( KMX ) announced the termination of its CEO and said that it expects Q3 comparable store used unit sales to decline 8% to 12% from a year ago. The news prompted one analyst to say, “[t]he story has quickly shifted to what we viewed as a value play to what’s now looking like a falling knife []” and the situation “appears to reflect deeper issues at KMX[.]”

“We’re focused on investors’ losses and whether CarMax ( KMX ) may have intentionally misled investors about the strength of its business model, actual growth prospects, and the quality of the CAF portfolio,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in CarMax ( KMX ) and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to frequently asked questions about the CarMax ( KMX ) case and our investigation, read more »

Whistleblowers: Persons with non-public information regarding CarMax ( KMX ) should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Contact:

Reed Kathrein, 844-916-0895

Image: https://www.globenewswire.com/newsroom/ti?nf=OTU5MTU2NiM3MjkwNjY1IzIwMTg1MzI=

Image: https://ml.globenewswire.com/media/YmQ0YTFkM2YtNDk5ZS00YjY1LWIxNTEtY2EwZDYzYjM2Zjg5LTEwMzAxMDUtMjAyNS0xMS0yNC1lbg==/tiny/Hagens-Berman-Sobol-Shapiro-LL.png Image: Primary Logo

Source: Hagens Berman Sobol Shapiro LLP

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jones Lang LaSalle Offers Steady Growth Outlook, UBS Says
Jones Lang LaSalle Offers Steady Growth Outlook, UBS Says
Nov 17, 2025
02:58 PM EST, 11/17/2025 (MT Newswires) -- Jones Lang LaSalle ( JLL ) is set to benefit from improving industry tailwinds amid attractive valuation after its Q3 results, UBS Securities said in a Sunday note. The report pointed to an outlook downgrade for its Real Estate Management Services segment for the next several quarters while Q3 margin expansion disappointed, similar...
Target May Tighten 2025 Outlook as Q3 Comps Stay Weak, Oppenheimer Says
Target May Tighten 2025 Outlook as Q3 Comps Stay Weak, Oppenheimer Says
Nov 17, 2025
02:46 PM EST, 11/17/2025 (MT Newswires) -- Target ( TGT ) is likely to post soft Q3 on Wednesday with comparable sales down about 2% and could narrow its fiscal 2025 earnings per share guidance toward the low end of its $7 to $9 range, Oppenheimer said Monday in a pre-results report. Oppenheimer said it added conservatism to its Q4...
Liberty Defense Up Near 14% On Contract Win for Multiple HEXWAVE Walkthrough Screening Systems From a U.S. State Capitol Complex
Liberty Defense Up Near 14% On Contract Win for Multiple HEXWAVE Walkthrough Screening Systems From a U.S. State Capitol Complex
Nov 17, 2025
03:04 PM EST, 11/17/2025 (MT Newswires) -- Liberty Defense Holdings ( LDDFF ) shares were up near 14% on Monday after it received a competitive bid award for three HEXWAVE walkthrough screening systems at a U.S. State Capitol complex in the Northeast. The company said the systems will support security screening for officials, employees, and visitors across two high-traffic buildings....
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
Nov 17, 2025
Jazz Pharmaceuticals Plc ( JAZZ ) shares are popping on Monday following the company’s positive results of its Phase 3 HERIZON-GEA-01 trial, which assessed Ziihera in combination with chemotherapy, with or without the PD-1 inhibitor Tevimbra, as a first-line treatment for HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). What Happened: When compared to the control group that received trastuzumab...
Copyright 2023-2025 - www.financetom.com All Rights Reserved